...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
【24h】

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.

机译:基因组拷贝数分析显示滤泡淋巴瘤转化中涉及的基因组异常。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Follicular lymphoma (FL), the second most common type of non-Hodgkin lymphoma in the western world, is characterized by the t(14;18) translocation, which is present in up to 90% of cases. We studied 277 lymphoma samples (198 FL and 79 transformed FL [tFL]) using a single-nucleotide polymorphism array to identify the secondary chromosomal abnormalities that drive the development of FL and its transformation to diffuse large B-cell lymphoma. Common recurrent chromosomal abnormalities in FL included gains of 2, 5, 7, 6p, 8, 12, 17q, 18, 21, and X and losses on 6q and 17p. We also observed many frequent small abnormalities, including losses of 1p36.33-p36.31, 6q23.3-q24.1, and 10q23.1-q25.1 and gains of 2p16.1-p15, 8q24.13-q24.3, and 12q12-q13.13, and identified candidate genes that may be driving this selection. Recurrent abnormalities more frequent in tFL samples included gains of 3q27.3-q28 and chromosome 11 and losses of 9p21.3 and 15q. Four abnormalities, gain of X or Xp and losses of 6q23.2-24.1 or 6q13-15, predicted overall survival. Abnormalities associated with transformation of the disease likely impair immune surveillance, activate the nuclear factor-κB pathway, and deregulate p53 and B-cell transcription factors.
机译:卵泡淋巴瘤(FL),西方世界的第二种最常见的非霍奇金淋巴瘤类型,其特征在于T(14; 18)易位,其含量高达90%。我们使用单核苷酸多态性阵列研究了277个淋巴瘤样品(198FL和79转化的FL [TFL],以鉴定驱动FL的发育及其转化以扩散大B细胞淋巴瘤的二级染色体异常。 FL的常见复发染色体异常包括2,5,7,6p,8,12,111,12,111,12,11,18,21和x和6q和17p的损失。我们还观察到许多频繁的小异常,包括1p36.33-p36.31,6q23-q-q24.1和10q23.1-q25.1的损失,以及2p16.1-p15,8q24.13-q24的收益。图3和12Q12-Q13.13,并确定了可能驾驶该选择的候选基因。在TFL样品中更频繁频繁的复发异常包括3Q27.3-Q28和染色体11和9p21.3和15q的染色体。四个异常,增益X或XP和损失为6季度,6季度,预测总体生存。与疾病转化相关的异常可能会损害免疫监测,激活核因子-κB途径,并浸没P53和B细胞转录因子。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号